Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	13.75B -43.3%
Revenue (ttm)	1.08B -18.6%
Net Income	24.59M -59.5%
EPS	0.03 -55.5%
Shares Out	966.49M
PE Ratio	559.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,967,093
Open	14.31
Previous Close	14.44
Day's Range	14.11 - 14.73
52-Week Range	14.13 - 30.20
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,480
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2025, SHE:000766's revenue was 1.17 billion, a decrease of -11.54% compared to the previous year's 1.32 billion. Earnings were 34.29 million, a decrease of -39.25%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error